NCT00276458View on ClinicalTrials.gov

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Hypercholesterolemia
Interventions
DRUG

Comparator: atorvastatin

Atorvastatin 40mg tablet po qd (by mouth, once a day) for 6 weeks

DRUG

Comparator: Placebo

Atorvastatin 20mg Pbo and ezetimibe 10mg Pbo tablets po qd (by mouth, once a day). for 6 weeks

DRUG

Comparator: ezetimibe

Atorvastatin 20mg and ezetimibe 10mg tablets po qd (by mouth, once a day). for 6 weeks.

DRUG

Comparator: Placebo.

Atorvastatin 40mg Pbo tablets po qd (by mouth, once a day). for 6 weeks.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00276458 - To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED) | Biotech Hunter | Biotech Hunter